Thyrocare Technologies Limited

BSE: 539871 NSE: THYROCARE
Thyrocare Technologies Limited - healthcare in Navi Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L85110MH2000PLC123882 Incorporated 28 January 2000 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Listed - NSE: THYROCARE · BSE: 539871 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹829.04 Cr
▲ 20.61% YoY
EBITDA · FY 2026
₹279.03 Cr
▲ 35.99% YoY
Net profit · FY 2026
₹162.85 Cr
▲ 79.45% YoY
Authorised capital
₹300 Cr
Registered with MCA
Paid-up capital
₹159.16 Cr
Issued & subscribed
Open charges
None
Satisfied ₹45.05 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
1,758
Latest available

About Thyrocare Technologies Limited

Data last updated: 05 January 2026

Thyrocare Technologies Limited is a public limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Docon Technologies Private Limited. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 28 January 2000, the company has been in operation for over 26 years.

Registered with ROC Mumbai under CIN L85110MH2000PLC123882. Listed on BSE: 539871 and NSE: THYROCARE.

Capital: an authorised share capital of ₹300 Cr and a paid-up capital of ₹159.16 Cr. It is led by directors including Nishant Amilal Shah and Harshil Jiten Vora.

Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: D37/1 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703.

As per the financials filed for FY 2025, the company reported a revenue of ₹702.18 Cr, a growth of 21% compared to the previous year.

The company has a workforce of approximately 1,758 employees as per the latest available data. It operates as a subsidiary of Docon Technologies Private Limited. Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Healthcareontime, Thyrocare. As per MCA filings, the company has satisfied charges of ₹45.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thyrocare.com.

Company Details of Thyrocare Technologies Limited
CIN L85110MH2000PLC123882
Registration Number 123882
Incorporation Date 28 January 2000
ROC Mumbai
Listing Status Listed (BSE: 539871, NSE: THYROCARE)
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Docon Technologies Private Limited
Compliance Status Active Compliant
Key People
Rahul Franklin Guha Managing Director Nishant Amilal Shah Director Harshil Jiten Vora Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    thyrocare.com
  • Social Media
  • Apps
  • Registered Address
    D37/1 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Thyrocare Technologies Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Thyrocare Technologies Limited report

Financials, compliance, directors, charges, ownership and filings for Thyrocare Technologies Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Thyrocare Technologies Limited

Thyrocare Technologies Limited has one previous CIN (Corporate Identification Number): U85110MH2000PLC123882. The current CIN is L85110MH2000PLC123882, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L85110MH2000PLC123882 Current
U85110MH2000PLC123882 Previous

Associated Brands with Thyrocare Technologies Limited

Thyrocare Technologies Limited operates two associated brands: HealthcareOnTime and Thyrocare. These brands represent Thyrocare Technologies Limited's diversified market presence and brand portfolio.

Brand Description Website
Thyrocare
Diagnostic testing centers for pathology and health screenings are operated. thyrocare.com
HealthcareOnTime
HealthcareOnTime provides online diagnostic and at-home health testing services in India. healthcareontime.com

Competitors & Alternatives of Thyrocare Technologies Limited

Brands and companies operating in the same space as Thyrocare Technologies Limited include Krsnaa Diagnostics, Suraksha Diagnostics, Vijaya Diagnostic Centre and 6 more.

Competitor Description Location Founded
Krsnaa Diagnostics Krsnaa Diagnostics Chain of radiology & pathology laboratory centers Pune, India, India 2011
Suraksha Diagnostics Suraksha Diagnostics Pathology, molecular diagnostics, and imaging services are provided. Kolkata, India, India 2005
Vijaya Diagnostic Centre Vijaya Diagnostic Centre Diagnostic services are offered via a chain of centers. Hyderabad, India, India 1981
Igenetic Igenetic Provider molecular diagnostic solutions and services Mumbai, India, India 2013
PH Diagnostic Centre PH Diagnostic Centre Provider of medical diagnostic services including blood tests, urine tests, and specialized health check-ups Pune, India, India 2001
GD GD A chain of clinical laboratories is operated for diagnostic services. Mumbai, India, India 2007
Aarthi Scans Aarthi Scans Chain of diagnostic centers Chennai, India, India 2000
Primex Healthcare and Research Primex Healthcare and Research A chain of pathology and imaging labs is operated. Chennai, India, India 2010
Medall Medall Medical diagnostic services are provided through a chain of centres. Chennai, India, India 2008

Business Activity of Thyrocare Technologies Limited

Thyrocare Technologies Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q2 Medical and dental practice, Nursing, pathology, blood bank services, etc. *********

Auditor Details of Thyrocare Technologies Limited

Thyrocare Technologies Limited is audited by MSKA & ASSOCIATES LLP (Formerly Known as MSKA & Associates) (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
MSKA & ASSOCIATES LLP (Formerly Known as MSKA & Associates) (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Thyrocare Technologies Limited

Thyrocare Technologies Limited is currently managed by 11 directors, with 31 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nishant Amilal Shah
Also directs: Thyrocare Technologies Limited, Nueclear Healthcare Limited, Jackstien International Llp and 2 more
Director 15 Jun 2024 2 Years 0 Months Current
Harshil Jiten Vora
Also directs: Thyrocare Technologies Limited
Director 14 Jul 2023 2 Years 11 Months Current
Anandh Sundar
Also directs: Thyrocare Technologies Limited, Nueclear Healthcare Limited, Cera Sanitaryware Limited and 3 more
Director 15 Jun 2024 2 Years 0 Months Current
Indumati Gopinathan
Also directs: Thyrocare Technologies Limited
Director 12 Aug 2017 8 Years 10 Months Current
Alok Kumar Jagnani
Also directs: Pulse Hitech Health Services (Ghatkopar) Llp, Thyrocare Technologies Limited, Venkatesh Medico Private Limited and 3 more
Director 24 Jul 2025 0 Years 11 Months Current
Dhaval Rajesh Shah
Also directs: Thyrocare Technologies Limited, Nueclear Healthcare Limited, D Three S Consultancy Services Llp and 5 more
Director 06 Oct 2021 4 Years 9 Months Current
Showing 6 of 11 current directors. View all directors

Financials of Thyrocare Technologies Limited FY 2026 filings available

Thyrocare Technologies Limited reported revenue of ₹829.04 Cr (up 20.61% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹829.04 Cr ▲ 20.61%
Profit · FY 2026
₹162.85 Cr ▲ 79.45%
EBITDA · FY 2026
₹279.03 Cr ▲ 35.99%
Revenue₹ Cr · Consolidated05001,000FY 2020: ₹433 Cr433FY 2020FY 2021: ₹495 Cr · +14.2% YoY495+14.2%FY 2021FY 2022: ₹589 Cr · +19.1% YoY589+19.1%FY 2022FY 2023: ₹527 Cr · -10.6% YoY527-10.6%FY 2023FY 2024: ₹572 Cr · +8.6% YoY572+8.6%FY 2024FY 2025: ₹687 Cr · +20.2% YoY687+20.2%FY 2025FY 2026: ₹829 Cr · +20.6% YoY829+20.6%FY 2026
Net Profit₹ Cr · Consolidated0100200FY 2020: ₹88 Cr88.4FY 2020FY 2021: ₹113 Cr · +28% YoY113+28%FY 2021FY 2022: ₹176 Cr · +55.7% YoY176+55.7%FY 2022FY 2023: ₹64 Cr · -63.5% YoY64.4-63.5%FY 2023FY 2024: ₹69 Cr · +8% YoY69.5+8%FY 2024FY 2025: ₹91 Cr · +30.6% YoY90.8+30.6%FY 2025FY 2026: ₹163 Cr · +79.4% YoY163+79.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹157 Cr · +16.3% YoY157+16.3%Q1'25Q2'25: ₹177 Cr · +19.8% YoY177+19.8%Q2'25Q3'25: ₹166 Cr · +23.1% YoY166+23.1%Q3'25Q4'25: ₹187 Cr · +21.3% YoY187+21.3%Q4'25Q1'26: ₹193 Cr · +23% YoY193+23%Q1'26Q2'26: ₹217 Cr · +22.1% YoY217+22.1%Q2'26Q3'26: ₹196 Cr · +17.8% YoY196+17.8%Q3'26Q4'26: ₹224 Cr · +19.7% YoY224+19.7%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹829.04 Cr ₹687.35 Cr ₹571.88 Cr ₹526.67 Cr ₹588.86 Cr ₹494.62 Cr ₹433.2 Cr
Other Income ₹16.99 Cr ₹14.83 Cr ₹9.37 Cr ₹8.42 Cr ₹29.25 Cr ₹12.43 Cr ₹7.73 Cr
Total Income ₹846.03 Cr ₹702.18 Cr ₹581.25 Cr ₹535.09 Cr ₹618.11 Cr ₹507.05 Cr ₹440.93 Cr
Cost of Materials Consumed ₹218.71 Cr ₹188.27 Cr ₹164.51 Cr ₹156.92 Cr ₹166.25 Cr ₹162.53 Cr ₹114.92 Cr
Purchases of Stock-in-Trade ₹1.09 Cr ₹2 Cr ₹2.47 Cr ₹6.11 Cr ₹4.32 Cr ₹1.09 Cr ₹2.25 Cr
Changes in Inventories -₹23 Lakh ₹81 Lakh -₹28 Lakh ₹20 Lakh -₹88 Lakh ₹28 Lakh -₹8 Lakh
Employee Benefit Expense ₹138.06 Cr ₹126.77 Cr ₹107.86 Cr ₹106.15 Cr ₹61.13 Cr ₹58.07 Cr ₹48.92 Cr
Finance Costs ₹2.8 Cr ₹3.05 Cr ₹4.2 Cr ₹2.35 Cr ₹2.37 Cr ₹87 Lakh ₹1.85 Cr
Depreciation & Amortisation ₹58.58 Cr ₹55.26 Cr ₹47.01 Cr ₹38.71 Cr ₹33.87 Cr ₹30.28 Cr ₹31.91 Cr
Other Expenses ₹209.37 Cr ₹179.14 Cr ₹159.89 Cr ₹137.24 Cr ₹123.15 Cr ₹101.4 Cr ₹94.67 Cr
Total Expenses ₹628.38 Cr ₹555.3 Cr ₹485.66 Cr ₹447.68 Cr ₹390.21 Cr ₹354.52 Cr ₹294.44 Cr
Profit Before Exceptional Items & Tax ₹217.65 Cr ₹146.88 Cr ₹95.59 Cr ₹87.41 Cr ₹227.9 Cr ₹152.53 Cr ₹146.49 Cr
Exceptional Items -₹6.16 Cr ₹0 ₹0 ₹0 ₹0 ₹0 -₹6.58 Cr
Profit Before Tax ₹211.49 Cr ₹146.88 Cr ₹95.59 Cr ₹87.41 Cr ₹227.9 Cr ₹152.53 Cr ₹139.91 Cr
Total Tax Expense ₹50.03 Cr ₹54.69 Cr ₹26.49 Cr ₹24.23 Cr ₹51.58 Cr ₹39.32 Cr ₹52.01 Cr
Net Profit ₹162.85 Cr ₹90.75 Cr ₹69.49 Cr ₹64.36 Cr ₹176.14 Cr ₹113.14 Cr ₹88.41 Cr
  attributable to Owners ₹163.05 Cr ₹91.51 Cr ₹70.76 Cr ₹64.49 Cr - ₹0 -
  attributable to NCI -₹19 Lakh -₹76 Lakh -₹1.27 Cr -₹13 Lakh - ₹0 -
Other Comprehensive Income ₹38 Lakh -₹77 Lakh ₹29 Lakh ₹1.53 Cr -₹8 Lakh -₹1.39 Cr ₹12 Lakh
Total Comprehensive Income ₹163.23 Cr ₹89.98 Cr ₹69.78 Cr ₹65.89 Cr ₹176.06 Cr ₹111.75 Cr ₹88.53 Cr
EBITDA (computed) ₹279.03 Cr ₹205.19 Cr ₹146.8 Cr ₹128.47 Cr ₹264.14 Cr ₹183.68 Cr ₹180.25 Cr
Basic EPS ₹10.27 ₹17.13 ₹13.42 ₹12.16 ₹33.30 ₹21.41 ₹16.74
Diluted EPS ₹10.24 ₹17.08 ₹13.40 ₹12.14 ₹33.24 ₹21.37 ₹16.71
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹747.22 Cr ₹692.75 Cr ₹643.88 Cr ₹632.72 Cr
Non-current Assets ₹374.93 Cr ₹355.03 Cr ₹365.38 Cr ₹359.78 Cr
Current Assets ₹372.29 Cr ₹337.72 Cr ₹278.5 Cr ₹272.94 Cr
Property, Plant & Equipment ₹205.62 Cr ₹148.71 Cr ₹168.44 Cr ₹157.44 Cr
Inventories ₹48.46 Cr ₹46.54 Cr ₹47.52 Cr ₹27.67 Cr
Trade Receivables ₹73.88 Cr ₹73 Cr ₹43.47 Cr ₹85.12 Cr
Cash & Equivalents ₹38.32 Cr ₹17.68 Cr ₹9.3 Cr ₹17.77 Cr
Equity (Net Worth) ₹586.02 Cr ₹547.05 Cr ₹527.63 Cr ₹535.22 Cr
Equity Share Capital ₹159.17 Cr ₹52.99 Cr ₹52.95 Cr ₹52.93 Cr
Borrowings (Non-current) ₹0 ₹0 ₹10.91 Cr ₹0
Borrowings (Current) ₹0 ₹0 ₹10.69 Cr ₹0
Total Debt (computed) ₹0 ₹0 ₹21.6 Cr ₹0
Current Liabilities ₹109.91 Cr ₹121.84 Cr ₹90.48 Cr ₹77.1 Cr
Total Liabilities ₹161.2 Cr ₹145.7 Cr ₹116.25 Cr ₹97.5 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹213.24 Cr ₹191.32 Cr ₹167.64 Cr ₹129.31 Cr ₹266.99 Cr
Investing Cash Flow -₹23.01 Cr -₹52.52 Cr -₹91.29 Cr -₹38.99 Cr -₹119.71 Cr
Financing Cash Flow -₹169.59 Cr -₹130.42 Cr -₹84.8 Cr -₹86.18 Cr -₹146.85 Cr
Capital Expenditure ₹20.88 Cr ₹44.89 Cr ₹61.59 Cr ₹43.65 Cr ₹37.83 Cr
Free Cash Flow (computed) ₹192.36 Cr ₹146.43 Cr ₹106.05 Cr ₹85.66 Cr ₹229.16 Cr
Dividends Paid ₹148.43 Cr ₹95.31 Cr ₹95.27 Cr ₹79.35 Cr ₹79.31 Cr
Net Change in Cash ₹20.64 Cr ₹8.38 Cr -₹8.45 Cr ₹4.14 Cr ₹43 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹223.95 Cr ₹195.53 Cr ₹216.53 Cr ₹193.03 Cr ₹187.16 Cr ₹165.92 Cr ₹177.36 Cr ₹156.91 Cr ₹154.25 Cr ₹134.74 Cr ₹148 Cr ₹134.89 Cr
Other Income ₹4.31 Cr ₹4.98 Cr ₹3.05 Cr ₹4.65 Cr ₹4.59 Cr ₹4.01 Cr ₹2.61 Cr ₹3.62 Cr ₹3.49 Cr ₹2.73 Cr ₹2.17 Cr ₹98 Lakh
Total Income ₹228.26 Cr ₹200.51 Cr ₹219.58 Cr ₹197.68 Cr ₹191.75 Cr ₹169.93 Cr ₹179.96 Cr ₹160.53 Cr ₹157.74 Cr ₹137.47 Cr ₹150.17 Cr ₹135.87 Cr
Cost of Materials Consumed ₹56.42 Cr ₹47.07 Cr ₹59.81 Cr ₹55.41 Cr ₹48.71 Cr ₹44.79 Cr ₹50.12 Cr ₹44.65 Cr ₹46.12 Cr ₹38.01 Cr ₹43.08 Cr ₹37.3 Cr
Purchases of Stock-in-Trade ₹77 Lakh ₹4 Lakh ₹21 Lakh ₹7 Lakh ₹46 Lakh ₹20 Lakh ₹1.28 Cr ₹6 Lakh ₹1.06 Cr ₹68 Lakh ₹38 Lakh ₹35 Lakh
Changes in Inventories -₹51 Lakh ₹9 Lakh ₹4 Lakh ₹15 Lakh ₹30 Lakh ₹17 Lakh -₹41.3 Lakh ₹75 Lakh -₹61 Lakh -₹27 Lakh ₹18 Lakh ₹42 Lakh
Employee Benefit Expense ₹36.07 Cr ₹35.76 Cr ₹33.23 Cr ₹33 Cr ₹33.47 Cr ₹35.09 Cr ₹29.49 Cr ₹28.72 Cr ₹26.57 Cr ₹26.36 Cr ₹27.06 Cr ₹27.87 Cr
Finance Costs ₹1.52 Cr -₹9 Lakh ₹59 Lakh ₹78 Lakh ₹70 Lakh ₹60 Lakh ₹76.1 Lakh ₹99 Lakh ₹1.12 Cr ₹1.07 Cr ₹1.13 Cr ₹88 Lakh
Depreciation & Amortisation ₹14.03 Cr ₹21.63 Cr ₹11.51 Cr ₹11.41 Cr ₹13.77 Cr ₹17.06 Cr ₹13.07 Cr ₹11.36 Cr ₹13.06 Cr ₹13.47 Cr ₹10.65 Cr ₹9.83 Cr
Other Expenses ₹56.11 Cr ₹54.74 Cr ₹51.89 Cr ₹46.63 Cr ₹46.52 Cr ₹43.94 Cr ₹48.59 Cr ₹40.09 Cr ₹47.3 Cr ₹38.37 Cr ₹39.78 Cr ₹34.44 Cr
Total Expenses ₹164.41 Cr ₹159.24 Cr ₹157.28 Cr ₹147.45 Cr ₹143.93 Cr ₹141.85 Cr ₹142.9 Cr ₹126.62 Cr ₹134.62 Cr ₹117.69 Cr ₹122.26 Cr ₹111.09 Cr
Profit Before Exceptional Items & Tax ₹63.85 Cr ₹41.27 Cr ₹62.3 Cr ₹50.23 Cr ₹47.82 Cr ₹28.08 Cr ₹37.07 Cr ₹33.91 Cr ₹23.12 Cr ₹19.78 Cr ₹27.91 Cr ₹24.78 Cr
Exceptional Items ₹0 -₹6.16 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹22 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹63.85 Cr ₹35.11 Cr ₹62.3 Cr ₹50.23 Cr ₹47.82 Cr ₹28.08 Cr ₹37.07 Cr ₹33.91 Cr ₹22.9 Cr ₹19.78 Cr ₹27.91 Cr ₹24.78 Cr
Total Tax Expense ₹15.73 Cr ₹7.34 Cr ₹14.77 Cr ₹12.19 Cr ₹25.62 Cr ₹8.97 Cr -₹10.35 Cr ₹9.61 Cr ₹5.72 Cr ₹5.17 Cr ₹7.94 Cr ₹7.65 Cr
Net Profit ₹48.7 Cr ₹28.05 Cr ₹47.81 Cr ₹38.29 Cr ₹21.57 Cr ₹18.95 Cr ₹47.13 Cr ₹23.94 Cr ₹17.18 Cr ₹14.74 Cr ₹20.33 Cr ₹17.25 Cr
  attributable to Owners ₹47.12 Cr ₹29.01 Cr ₹47.99 Cr ₹38.93 Cr ₹21.7 Cr ₹19.11 Cr ₹26.67 Cr ₹24.17 Cr ₹17.79 Cr ₹15.35 Cr ₹20.34 Cr -
  attributable to NCI ₹1.59 Cr -₹96 Lakh -₹18.4 Lakh -₹64 Lakh -₹13 Lakh -₹16 Lakh -₹24.6 Lakh -₹23 Lakh -₹60 Lakh -₹61 Lakh -₹1 Lakh -
Other Comprehensive Income ₹66 Lakh -₹14 Lakh ₹9 Lakh -₹23 Lakh -₹23 Lakh -₹1 Lakh -₹5 Lakh -₹47 Lakh ₹6 Lakh ₹0 ₹8 Lakh ₹15 Lakh
Total Comprehensive Income ₹49.36 Cr ₹27.91 Cr ₹47.9 Cr ₹38.06 Cr ₹21.34 Cr ₹18.94 Cr ₹47.08 Cr ₹23.47 Cr ₹17.24 Cr ₹14.74 Cr ₹20.41 Cr ₹17.4 Cr
EBITDA (computed) ₹79.4 Cr ₹62.81 Cr ₹74.4 Cr ₹62.42 Cr ₹62.29 Cr ₹45.74 Cr ₹50.89 Cr ₹46.26 Cr ₹37.3 Cr ₹34.32 Cr ₹39.69 Cr ₹35.49 Cr
Basic EPS ₹2.99 ₹1.82 ₹9.05 ₹7.35 ₹4.17 ₹3.58 ₹4.99 ₹4.52 ₹3.54 ₹2.78 ₹3.84 ₹3.26
Diluted EPS ₹2.98 ₹1.81 ₹9.03 ₹7.33 ₹4.16 ₹3.56 ₹4.98 ₹4.51 ₹3.54 ₹2.77 ₹3.84 ₹3.25
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Diagnostic Testing Services ₹210.22 Cr ₹58.86 Cr ₹514.08 Cr ₹147.35 Cr
Imaging Services ₹12.48 Cr -₹30 Lakh ₹192.34 Cr ₹11.47 Cr
Others ₹1.25 Cr ₹98 Lakh ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Diagnostic Testing Services ₹772.53 Cr ₹197.48 Cr - -
Imaging Services ₹53.14 Cr ₹67 Lakh - -
Others ₹3.37 Cr ₹2.51 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹774.27 Cr ₹633.1 Cr ₹524.02 Cr ₹486.46 Cr ₹561.53 Cr ₹474.27 Cr ₹400 Cr
Other Income ₹13.39 Cr ₹13.34 Cr ₹7.18 Cr ₹5.39 Cr ₹7.4 Cr ₹12.28 Cr ₹10.48 Cr
Total Income ₹787.66 Cr ₹646.44 Cr ₹531.2 Cr ₹491.85 Cr ₹568.93 Cr ₹486.55 Cr ₹410.48 Cr
Cost of Materials Consumed ₹208.37 Cr ₹177.28 Cr ₹155.39 Cr ₹150.06 Cr ₹161.79 Cr ₹159.18 Cr ₹110.17 Cr
Purchases of Stock-in-Trade ₹1.09 Cr ₹2 Cr ₹2.47 Cr ₹6.11 Cr ₹4.32 Cr ₹1.09 Cr ₹2.25 Cr
Changes in Inventories -₹23 Lakh ₹81 Lakh -₹28 Lakh ₹20 Lakh -₹88 Lakh ₹28 Lakh -₹8 Lakh
Employee Benefit Expense ₹128.29 Cr ₹118.56 Cr ₹102.92 Cr ₹102.61 Cr ₹58.82 Cr ₹56.79 Cr ₹45.75 Cr
Finance Costs ₹2.18 Cr ₹2.63 Cr ₹3.73 Cr ₹2.25 Cr ₹2.38 Cr ₹66 Lakh ₹1.32 Cr
Depreciation & Amortisation ₹51.17 Cr ₹46.52 Cr ₹39.11 Cr ₹34.08 Cr ₹28.47 Cr ₹21.08 Cr ₹19.54 Cr
Other Expenses ₹180.42 Cr ₹147.43 Cr ₹129.64 Cr ₹115.47 Cr ₹106.65 Cr ₹86.19 Cr ₹75.2 Cr
Total Expenses ₹571.29 Cr ₹495.23 Cr ₹432.98 Cr ₹410.78 Cr ₹361.55 Cr ₹325.27 Cr ₹254.15 Cr
Profit Before Exceptional Items & Tax ₹216.37 Cr ₹151.21 Cr ₹98.22 Cr ₹81.07 Cr ₹207.38 Cr ₹161.28 Cr ₹156.33 Cr
Exceptional Items -₹5.97 Cr ₹0 ₹0 ₹0 ₹0 ₹0 -₹44.33 Cr
Profit Before Tax ₹210.4 Cr ₹151.21 Cr ₹98.22 Cr ₹81.07 Cr ₹207.38 Cr ₹161.28 Cr ₹112 Cr
Total Tax Expense ₹61.59 Cr ₹55.43 Cr ₹27.08 Cr ₹24.1 Cr ₹55.33 Cr ₹41.51 Cr ₹32.68 Cr
Net Profit ₹148.81 Cr ₹95.78 Cr ₹71.14 Cr ₹56.97 Cr ₹152.05 Cr ₹119.77 Cr ₹79.32 Cr
Other Comprehensive Income ₹22 Lakh -₹73 Lakh ₹22 Lakh ₹1.54 Cr -₹4 Lakh -₹1.41 Cr ₹12 Lakh
Total Comprehensive Income ₹149.03 Cr ₹95.05 Cr ₹71.36 Cr ₹58.51 Cr ₹152.01 Cr ₹118.36 Cr ₹79.44 Cr
EBITDA (computed) ₹269.72 Cr ₹200.36 Cr ₹141.06 Cr ₹117.4 Cr ₹238.23 Cr ₹183.02 Cr ₹177.19 Cr
Basic EPS ₹9.36 ₹17.95 ₹13.44 ₹10.77 ₹28.75 ₹22.66 ₹15.02
Diluted EPS ₹9.34 ₹17.90 ₹13.41 ₹10.75 ₹28.70 ₹22.62 ₹14.99
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹711.21 Cr ₹676.35 Cr ₹620.28 Cr ₹611.87 Cr
Non-current Assets ₹395.4 Cr ₹377.79 Cr ₹374.63 Cr ₹376.5 Cr
Current Assets ₹315.81 Cr ₹298.56 Cr ₹245.65 Cr ₹235.37 Cr
Property, Plant & Equipment ₹171.96 Cr ₹113.66 Cr ₹127.84 Cr ₹123.52 Cr
Inventories ₹46.56 Cr ₹45.7 Cr ₹45.69 Cr ₹27.05 Cr
Trade Receivables ₹69.53 Cr ₹68.94 Cr ₹40.2 Cr ₹83.31 Cr
Cash & Equivalents ₹32.88 Cr ₹15.18 Cr ₹3.56 Cr ₹12.53 Cr
Equity (Net Worth) ₹560.68 Cr ₹537.1 Cr ₹513.81 Cr ₹521.04 Cr
Equity Share Capital ₹159.17 Cr ₹52.99 Cr ₹52.95 Cr ₹52.93 Cr
Borrowings (Non-current) ₹0 ₹0 ₹10.91 Cr ₹0
Borrowings (Current) ₹0 ₹0 ₹8.86 Cr ₹0
Total Debt (computed) ₹0 ₹0 ₹19.77 Cr ₹0
Current Liabilities ₹95.43 Cr ₹110.96 Cr ₹75.96 Cr ₹73.2 Cr
Total Liabilities ₹150.53 Cr ₹139.25 Cr ₹106.47 Cr ₹90.83 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹206.07 Cr ₹190.76 Cr ₹155.2 Cr ₹120.01 Cr ₹105.68 Cr
Investing Cash Flow -₹20.92 Cr -₹54.7 Cr -₹80.28 Cr -₹31.48 Cr -₹12.32 Cr
Financing Cash Flow -₹167.45 Cr -₹124.44 Cr -₹83.71 Cr -₹87.5 Cr -₹86.91 Cr
Capital Expenditure ₹18.93 Cr ₹46.95 Cr ₹43.27 Cr ₹21.12 Cr ₹40.41 Cr
Free Cash Flow (computed) ₹187.14 Cr ₹143.81 Cr ₹111.93 Cr ₹98.89 Cr ₹65.27 Cr
Dividends Paid ₹148.43 Cr ₹95.31 Cr ₹95.27 Cr ₹79.35 Cr ₹79.31 Cr
Net Change in Cash ₹17.7 Cr ₹11.62 Cr -₹8.79 Cr ₹1.03 Cr ₹6.45 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹210.67 Cr ₹182.48 Cr ₹202.23 Cr ₹178.89 Cr ₹173.87 Cr ₹152.55 Cr ₹163.05 Cr ₹143.63 Cr ₹141.23 Cr ₹122.89 Cr ₹136.29 Cr ₹123.61 Cr
Other Income ₹3.72 Cr ₹3.43 Cr ₹2.28 Cr ₹3.96 Cr ₹4.54 Cr ₹3.51 Cr ₹2.12 Cr ₹3.17 Cr ₹2.81 Cr ₹2.09 Cr ₹1.82 Cr ₹46 Lakh
Total Income ₹214.39 Cr ₹185.91 Cr ₹204.51 Cr ₹182.85 Cr ₹178.41 Cr ₹156.06 Cr ₹165.17 Cr ₹146.8 Cr ₹144.04 Cr ₹124.98 Cr ₹138.11 Cr ₹124.07 Cr
Cost of Materials Consumed ₹54.27 Cr ₹44.61 Cr ₹57.12 Cr ₹52.37 Cr ₹46.19 Cr ₹42.05 Cr ₹46.94 Cr ₹42.11 Cr ₹43.6 Cr ₹35.99 Cr ₹40.7 Cr ₹35.1 Cr
Purchases of Stock-in-Trade ₹77 Lakh ₹4 Lakh ₹21 Lakh ₹7 Lakh ₹46 Lakh ₹20 Lakh ₹1.29 Cr ₹6 Lakh ₹1.06 Cr ₹68 Lakh ₹38 Lakh ₹35 Lakh
Changes in Inventories -₹51 Lakh ₹9 Lakh ₹4 Lakh ₹15 Lakh ₹30 Lakh ₹17 Lakh -₹41.3 Lakh ₹75 Lakh -₹61 Lakh -₹27 Lakh ₹18 Lakh ₹42 Lakh
Employee Benefit Expense ₹33.44 Cr ₹32.78 Cr ₹31.37 Cr ₹30.7 Cr ₹31.33 Cr ₹32.96 Cr ₹27.69 Cr ₹26.57 Cr ₹25.12 Cr ₹25.06 Cr ₹25.87 Cr ₹26.88 Cr
Finance Costs ₹1.43 Cr -₹47 Lakh ₹60 Lakh ₹62 Lakh ₹60 Lakh ₹48 Lakh ₹63.4 Lakh ₹93 Lakh ₹94 Lakh ₹96 Lakh ₹1.02 Cr ₹80 Lakh
Depreciation & Amortisation ₹12.94 Cr ₹19.58 Cr ₹9.7 Cr ₹8.95 Cr ₹11.78 Cr ₹15.34 Cr ₹9.94 Cr ₹9.45 Cr ₹10.41 Cr ₹10.9 Cr ₹9.3 Cr ₹8.51 Cr
Other Expenses ₹50.07 Cr ₹46.69 Cr ₹44.58 Cr ₹39.08 Cr ₹39.95 Cr ₹36.92 Cr ₹38.77 Cr ₹31.79 Cr ₹38.47 Cr ₹30.9 Cr ₹32.53 Cr ₹27.74 Cr
Total Expenses ₹152.41 Cr ₹143.32 Cr ₹143.62 Cr ₹131.94 Cr ₹130.61 Cr ₹128.12 Cr ₹124.84 Cr ₹111.66 Cr ₹118.99 Cr ₹104.22 Cr ₹109.98 Cr ₹99.8 Cr
Profit Before Exceptional Items & Tax ₹61.98 Cr ₹42.59 Cr ₹60.89 Cr ₹50.91 Cr ₹47.8 Cr ₹27.94 Cr ₹40.34 Cr ₹35.14 Cr ₹25.05 Cr ₹20.76 Cr ₹28.13 Cr ₹24.27 Cr
Exceptional Items ₹0 -₹5.97 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹61.98 Cr ₹36.62 Cr ₹60.89 Cr ₹50.91 Cr ₹47.8 Cr ₹27.94 Cr ₹40.34 Cr ₹35.14 Cr ₹25.05 Cr ₹20.76 Cr ₹28.13 Cr ₹24.27 Cr
Total Tax Expense ₹18.4 Cr ₹10.47 Cr ₹17.86 Cr ₹14.86 Cr ₹25.85 Cr ₹8.84 Cr ₹10.75 Cr ₹9.99 Cr ₹5.82 Cr ₹5.87 Cr ₹7.84 Cr ₹7.54 Cr
Net Profit ₹43.58 Cr ₹26.15 Cr ₹43.03 Cr ₹36.05 Cr ₹21.95 Cr ₹19.1 Cr ₹29.59 Cr ₹25.15 Cr ₹19.23 Cr ₹14.89 Cr ₹20.29 Cr ₹16.73 Cr
Other Comprehensive Income ₹48 Lakh -₹12 Lakh ₹7 Lakh -₹21 Lakh -₹23 Lakh -₹1 Lakh -₹5 Lakh -₹43 Lakh ₹0 ₹1 Lakh ₹5 Lakh ₹16 Lakh
Total Comprehensive Income ₹44.06 Cr ₹26.03 Cr ₹43.1 Cr ₹35.84 Cr ₹21.72 Cr ₹19.09 Cr ₹29.54 Cr ₹24.72 Cr ₹19.23 Cr ₹14.9 Cr ₹20.34 Cr ₹16.89 Cr
EBITDA (computed) ₹76.35 Cr ₹61.7 Cr ₹71.19 Cr ₹60.48 Cr ₹60.18 Cr ₹43.76 Cr ₹50.91 Cr ₹45.52 Cr ₹36.4 Cr ₹32.62 Cr ₹38.45 Cr ₹33.58 Cr
Basic EPS ₹2.75 ₹1.64 ₹8.12 ₹6.80 ₹4.08 ₹3.53 ₹5.59 ₹4.75 ₹3.63 ₹2.81 ₹3.83 ₹3.16
Diluted EPS ₹2.75 ₹1.63 ₹8.11 ₹6.78 ₹4.07 ₹3.51 ₹5.58 ₹4.74 ₹3.63 ₹2.80 ₹3.83 ₹3.16
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Thyrocare Technologies Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Thyrocare Technologies Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 60.92%, foreign institutional investors hold 5.37%, domestic institutional investors hold 20.99%, retail and other public shareholders hold 12.71% of Thyrocare Technologies Limited. The company had 73,377 shareholders on record.

Promoters: 60.92%DII (Domestic Institutional): 20.99%FII (Foreign Institutional): 5.37%Retail & Others: 12.71%
Mar 2026
QUARTER
60.92% Promoters
20.99% DII (Domestic Institutional)
5.37% FII (Foreign Institutional)
12.71% Retail & Others
Promoter holding - history
Now 60.92% · Mar 2026High 71.22% · Sep 2021Low 60.92% · Mar 2026
59%62.5%66%69.5%73%May 2016Sep 2018Mar 2021Sep 2023Mar 2026May 2016: 63.96%Jun 2016: 63.96%Sep 2016: 63.96%Dec 2016: 63.96%Mar 2017: 63.96%Jun 2017: 63.96%Sep 2017: 63.96%Dec 2017: 63.96%Mar 2018: 63.96%Jun 2018: 63.96%Sep 2018: 63.96%Dec 2018: 65.12%Mar 2019: 65.71%Jun 2019: 65.95%Sep 2019: 66.06%Dec 2019: 66.01%Mar 2020: 66.01%Jun 2020: 66.04%Sep 2020: 66.11%Dec 2020: 66.14%Mar 2021: 66.14%Jun 2021: 66.14%Sep 2021: 71.22%Dec 2021: 71.18%Mar 2022: 71.18%Jun 2022: 71.18%Sep 2022: 71.14%Dec 2022: 71.14%Mar 2023: 71.14%Jun 2023: 71.14%Sep 2023: 71.14%Dec 2023: 71.11%Mar 2024: 71.11%Jun 2024: 71.11%Sep 2024: 71.11%Dec 2024: 71.06%Mar 2025: 71.06%Jun 2025: 71.06%Sep 2025: 71.06%Dec 2025: 60.93%Mar 2026: 60.92%71.22%60.92%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters60.92%60.93%71.06%71.06%71.06%71.06%
Public39.08%39.07%28.94%28.94%28.94%28.94%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Promoters60.92%71.06%71.11%71.14%71.18%66.14%66.01%65.71%63.96%63.96%
Public39.08%28.94%28.89%28.86%28.82%33.86%33.99%34.29%36.04%35.79%
Employee Trusts0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.25%
Promoter change (YoY, %pts)-10.14-0.05-0.03-0.04+5.04+0.13+0.30+1.75+0.00-

Board & Governance of Thyrocare Technologies Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Thyrocare Technologies Limited has 9 directors - 5 independent and 1 executive. The board is chaired by Rahul Guha.

DirectorPositionOn board sinceListed boards
Rahul Guha Executive Director · CEO-MD · Chairperson 2022-05-04 1
Dharmil Nirupam Sheth Non-Executive - Non Independent Director 2021-09-02 1
Dhaval Rajesh Shah Non-Executive - Non Independent Director 2021-10-06 1
Alok Kumar Jagnani Non-Executive - Non Independent Director 2025-07-24 1
Indumati Gopinathan Non-Executive - Independent Director 2017-08-12 2
Prapti Ishwar Gilada Non-Executive - Independent Director 2023-07-14 1
Harshil Jiten Vora Non-Executive - Independent Director 2023-07-14 1
Anandh Sundar Non-Executive - Independent Director 2024-06-15 2
Nishant A Shah Non-Executive - Independent Director 2024-06-15 1
Board Committees
CommitteeMembers
Audit Committee Nishant A Shah (Chairperson), Anandh Sundar, Prapti Ishwar Gilada, Rahul Guha
Nomination and remuneration committee Prapti Ishwar Gilada (Chairperson), Indumati Gopinathan, Dharmil Nirupam Sheth
Stakeholders Relationship Committee Prapti Ishwar Gilada (Chairperson), Dharmil Nirupam Sheth, Alok Kumar Jagnani
Risk Management Committee Prapti Ishwar Gilada (Chairperson), Dharmil Nirupam Sheth, Rahul Guha, Alok Kumar Jagnani
Corporate Social Responsibility Committee Indumati Gopinathan (Chairperson), Dhaval Rajesh Shah, Alok Kumar Jagnani

Group Structure of Thyrocare Technologies Limited

Thyrocare Technologies Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Thyrocare Technologies Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Nueclear Healthcare Limited U74120MH2011PLC212839 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Thyrocare Technologies Limited

Open charges
₹0
Satisfied charges
₹45.05 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹45.00 Cr
Uti Bank Ltd;₹0.05 Cr
Latest charge details
DateLenderAmountStatus
29 Apr 2023 Hdfc Bank Limited ₹45 Cr Satisfied
29 Apr 2002 Uti Bank Ltd; ₹4.62 Lakh Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Thyrocare Technologies Limited

Thyrocare Technologies Limited has a workforce of 1,758 employees as of Apr 07, 2024.

Employee count
1,758
Active EPFO establishments
2
Employee growth
-6.09%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Thyrocare Technologies Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Thyrocare Technologies Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Thyrocare Technologies Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Thyrocare Technologies Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Thyrocare Technologies Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Thyrocare Technologies Limited

MSME Payment Delays by Thyrocare Technologies Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Thyrocare Technologies Limited

Subsidiaries & Group Companies of Thyrocare Technologies Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Thyrocare Technologies Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Thyrocare Technologies Limited

MCA Filings & Documents of Thyrocare Technologies Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Thyrocare Technologies Limited

Directors
21 Aug 2025
Vikram Gupta was appointed as a Cfo on 21 Aug 2025 & has been associated with this company since 10 months 18 days.
Activity
31 Jul 2025
Thyrocare Technologies Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Directors
24 Jul 2025
Alok Kumar Jagnani was appointed as a Director on 24 Jul 2025 & has been associated with this company since 11 months 16 days.
Activity
31 Mar 2025
Thyrocare Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
13 Feb 2025
Brijesh Kumar was appointed as a Company Secretary on 13 Feb 2025 & has been associated with this company since 1 year 4 months.
Directors
31 Jan 2025
Brijesh Kumar was appointed as a Company Secretary on 31 Jan 2025 & has been associated with this company since 1 year 5 months.

Recent News on Thyrocare Technologies Limited

Stocks that will see action today: January 23, 2025
23 Jan 2025 · Thehindubusinessline
Thyrocare explores divesting radiology business
18 Sep 2024 · Thehindubusinessline

Frequently Asked Questions about Thyrocare Technologies Limited

Thyrocare Technologies Limited is an active public limited company in the healthcare sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 28 January 2000 (26+ years old) and is registered under CIN L85110MH2000PLC123882. Listed on BSE: 539871 and NSE: THYROCARE. The company has 1,758 employees.

Thyrocare Technologies Limited reported revenue of ₹702.18 Cr for FY 2025 (up 21.00% YoY).

The current directors of Thyrocare Technologies Limited are:

The primary industry of Thyrocare Technologies Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes. Thyrocare Technologies Limited is listed on both BSE (code: 539871) and NSE (symbol: THYROCARE).

Thyrocare Technologies Limited can be reached at the registered office: D371 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703, or through the website thyrocare.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available